Literature DB >> 23778154

Multi-institutional retrospective cohort study of spontaneous pneumothorax.

Deborah A Belchis1, Kris Shekitka, Christopher D Gocke.   

Abstract

Spontaneous pneumothorax (SP) affects only a subset of patients in a variety of disorders. This multi-institutional study attempted to identify unique clinicopathologic features of spontaneous pneumothorax (SP) in a large cohort. A total of 111 cases from 109 patients were retrieved from 3 institutions over an 11-year period: 27 women, 82 men. 66 were smokers, 16 were non-smokers, 27 unknown. Sixty-six cases (61%) had identifiable disorders (secondary SP). Seven patients had a family history of lung disease: 2 of pneumothorax, 2 of lung cancer, and 1 each of emphysema, COPD, and not further classified. Forty-three cases (32 men, 11 women) were primary. The average age was 28 (men) and 37 (women). 17 smoked, 14 were non-smokers, and 12 unknown. In 26%, a unique recently described entity, pneumothorax-associated fibroblastic lesion (PAFL), was noted. 16% of this subset also had cellular alveolar septae. Abundant intraalveolar macrophages were noted in 12 cases. Five cases of unknown etiology had extensive bullous lung disease not otherwise classified. One patient had unusual cellular areas suggestive of LAM but negative for HMB-45. In conclusion, several distinct morphologic lesions were identified: PAFL, a subset with cellular septae, and a third with numerous intraalveolar macrophages.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Multi-institutional cohort study; Pneumothorax-associated fibroblastic lesion; Spontaneous pneumothorax

Mesh:

Year:  2013        PMID: 23778154     DOI: 10.1016/j.prp.2013.05.002

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  1 in total

1.  [Management of spontaneous pneumothorax: about 138 cases].

Authors:  Bouchra Habibi; Leila Achachi; Sohaib Hayoun; Mohammed Raoufi; Laila Herrak; Mustapha El Ftouh
Journal:  Pan Afr Med J       Date:  2017-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.